Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.

Biotechnology

Bolden Therapeutics

The Cambridge office focuses on advancing research initiatives and supporting undergraduate research opportunities.

Cambridge

Bolden Therapeutics' headquarters in Providence, RI, United States

Johnny Page

Anne Valat

Maria Lopez-Bresnahan

Joel Richter

Ashley E. Webb

Stephen Salloway

Charles Polsky

Justin R. Fallon

The Research and Advisory team at Bolden Therapeutics is responsible for driving innovative research initiatives to develop groundbreaking therapeutics for central nervous system diseases. Composed of expert advisors and skilled scientists, the team collaborates to conduct cutting-edge studies, analyze data, and provide strategic insights that inform the company's R&D efforts and clinical strategies.

Research and Advisory

This department focuses on conducting and overseeing various research projects and initiatives.

Research Division

This department provides strategic direction and oversight for the organization.

Bolden Therapeutics

Org chart

Board & advisors

Teams

Research and Advisory

Research Division

Executive Leadership

Offices

Bolden Therapeutics

Org chart

Board & advisors

Teams

Research and Advisory

Research Division

Executive Leadership

Offices

Related companies